1. Home
  2. IVDA vs XAIR Comparison

IVDA vs XAIR Comparison

Compare IVDA & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

HOLD

Current Price

$0.23

Market Cap

3.7M

Sector

Technology

ML Signal

HOLD

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

BUY

Current Price

$2.09

Market Cap

3.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IVDA
XAIR
Founded
2003
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.0M
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
IVDA
XAIR
Price
$0.23
$2.09
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $20.00
AVG Volume (30 Days)
★ 176.6K
57.1K
Earning Date
11-13-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.38
N/A
EPS
★ N/A
N/A
Revenue
$4,468,279.00
★ $7,679,000.00
Revenue This Year
N/A
$4.23
Revenue Next Year
N/A
$108.84
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 132.98
107.26
52 Week Low
$0.21
$0.33
52 Week High
$1.52
$8.19

Technical Indicators

Market Signals
Indicator
IVDA
XAIR
Relative Strength Index (RSI) 37.90 36.57
Support Level $0.22 $2.05
Resistance Level $0.31 $3.30
Average True Range (ATR) 0.02 0.19
MACD -0.00 0.05
Stochastic Oscillator 18.32 19.48

Price Performance

Historical Comparison
IVDA
XAIR

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About XAIR Beyond Air Inc.

Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.

Share on Social Networks: